BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28163667)

  • 1. Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Hennig M; Hundt F; Busta S; Mikus S; Sanden PH; Sörgel A; Ruppert T
    Ger Med Sci; 2017; 15():Doc02. PubMed ID: 28163667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Russ H; Busta S; Jost B; Bethke TD
    Ger Med Sci; 2015; 13():Doc02. PubMed ID: 25698912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic considerations during outsourcing of clinical data management services].
    Shen T; Liu Y
    Yao Xue Xue Bao; 2015 Nov; 50(11):1493-7. PubMed ID: 26911050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking the pulse of strategic outsourcing relationships.
    Getz KA; Lamberti MJ; Kaitin KI
    Clin Ther; 2014 Oct; 36(10):1349-55. PubMed ID: 25444564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Outsourcing Oversight Practices and Performance.
    Wilkinson M; Harper B; Peacock J; Morrison R; Getz K
    Ther Innov Regul Sci; 2020 Jan; 54(1):158-166. PubMed ID: 32008252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug development process and COVID-19 pandemic: Flourishing era of outsourcing.
    Wasan H; Singh D; Reeta KH; Gupta P; Gupta YK
    Indian J Pharmacol; 2022; 54(5):364-372. PubMed ID: 36537406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outsourcing lead optimization: the eye of the storm.
    Clark DE
    Drug Discov Today; 2011 Feb; 16(3-4):147-57. PubMed ID: 21145413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outsourcing bioanalytical services at Janssen Research and Development: the sequel anno 2017.
    Dillen L; Verhaeghe T
    Bioanalysis; 2017 Aug; 9(15):1195-1201. PubMed ID: 28762758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharma Collaboration for Transparent Medical Information (phactMI™) Benchmark Study: Results of Organizational Structure and Resourcing of Medical Information Services in Support of Building Departmental Strategies.
    Marasigan K; Doshi S; Fung S
    Ther Innov Regul Sci; 2020 Nov; 54(6):1269-1274. PubMed ID: 33123969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials integrity: a CRO perspective.
    Beach JE
    Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of bioanalytical outsourcing: a pharma perspective.
    Bioanalysis; 2017 Aug; 9(15):1165-1169. PubMed ID: 28795582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint recommendations for a total services account as a factor in simplifying contracts.
    Bruns I; Schade-Brittinger C; Wissing F; Ruppert T; Trillsch M
    Ger Med Sci; 2019; 17():Doc10. PubMed ID: 31728135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Big-pharmaceuticalisation: clinical trials and Contract Research Organisations in India.
    Sariola S; Ravindran D; Kumar A; Jeffery R
    Soc Sci Med; 2015 Apr; 131():239-46. PubMed ID: 25476783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conference report: a hitchhiker's guide to outsourcing ADME studies: the inside of outsourcing.
    Pritchard JF; Anderson SR; Breuckner C; Premkumar ND; Polli JW
    Bioanalysis; 2013 Feb; 5(4):403-5. PubMed ID: 23414372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of Outsourcing Strategy and IT Technology in Clinical Trials.
    Stamenovic M; Dobraca A
    Acta Inform Med; 2017 Sep; 25(3):203-207. PubMed ID: 29114116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.